Details of the Drug

General Information of Drug (ID: DMT09TV)

• Drug Name: Immunoxel

Indication

Disease Entry	ICD 11	Status	REF
Tuberculosis	1B10-1B14	Phase 3	[1]

• Cross-matching ID: TTD ID: D2TH9K

References

• [1] ClinicalTrials.gov (NCT01061593) Phase III, Double-blind, Placebo-controlled, Randomized, 1-month Clinical Trial of Immunoxel Combined With Anti-TB Therapy Versus Anti-TB Therapy With Placebo. U.S.National Institutes of Health.